{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T15:31:25Z","timestamp":1781105485374,"version":"3.54.1"},"reference-count":15,"publisher":"American Medical Association (AMA)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Ophthalmol"],"published-print":{"date-parts":[[2022,6,1]]},"DOI":"10.1001\/jamaophthalmol.2022.1000","type":"journal-article","created":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T01:02:19Z","timestamp":1651194139000},"page":"639","source":"Crossref","is-referenced-by-count":17,"title":["Google Searches for Thyroid Eye Disease After Regulatory Approval of Teprotumumab"],"prefix":"10.1001","volume":"140","author":[{"given":"Jason C.","family":"Strawbridge","sequence":"first","affiliation":[{"name":"David Geffen School of Medicine, University of California Los Angeles, Los Angeles"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elana A.","family":"Meer","sequence":"additional","affiliation":[{"name":"University of Pennsylvania Perelman School of Medicine, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pallavi","family":"Singh","sequence":"additional","affiliation":[{"name":"Stein Eye Institute, Division of Orbital and Ophthalmic Plastic Surgery, University of California Los Angeles, Los Angeles"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel B.","family":"Rootman","sequence":"additional","affiliation":[{"name":"Stein Eye Institute, Division of Orbital and Ophthalmic Plastic Surgery, University of California Los Angeles, Los Angeles"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"10","key":"ebr220007r1","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1089\/thy.2016.0229","article-title":"2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis.","volume":"26","author":"Ross","year":"2016","journal-title":"Thyroid"},{"issue":"3","key":"ebr220007r5","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.soard.2013.10.007","article-title":"Bariatric surgery interest around the world: what Google Trends can teach us.","volume":"10","author":"Linkov","year":"2014","journal-title":"Surg Obes Relat Dis"},{"issue":"5","key":"ebr220007r6","doi-asserted-by":"publisher","DOI":"10.2196\/jmir.2102","article-title":"FluBreaks: early epidemic detection from Google flu trends.","volume":"14","author":"Pervaiz","year":"2012","journal-title":"J Med Internet Res"},{"issue":"9","key":"ebr220007r7","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1016\/j.ophtha.2019.04.008","article-title":"Google searches and detection of conjunctivitis epidemics worldwide.","volume":"126","author":"Deiner","year":"2019","journal-title":"Ophthalmology"},{"key":"ebr220007r8","doi-asserted-by":"publisher","DOI":"10.1080\/09286586.2021.1904513","article-title":"Public interest in cataract surgery: analysis and implications of Google Trends data from 14 European countries.","author":"Skrzypczak","journal-title":"Ophthalmic Epidemiol"},{"issue":"12","key":"ebr220007r10","doi-asserted-by":"publisher","first-page":"e1010","DOI":"10.1093\/cid\/ciaa1780","article-title":"Estimated incidence of coronavirus disease 2019 (COVID-19) illness and hospitalization\u2014US, February-September 2020.","volume":"72","author":"Reese","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"1","key":"ebr220007r12","doi-asserted-by":"publisher","first-page":"13136","DOI":"10.1038\/s41598-021-92204-0","article-title":"Worldwide antipsychotic drug search intensities: pharmacoepidemological estimations based on Google Trends data.","volume":"11","author":"\u00c5gren","year":"2021","journal-title":"Sci Rep"},{"issue":"4","key":"ebr220007r13","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1007\/s11606-014-3063-y","article-title":"The effect of competing direct-to-consumer advertising campaigns on the use of drugs for benign prostatic hyperplasia: time series analysis.","volume":"30","author":"Skeldon","year":"2015","journal-title":"J Gen Intern Med"},{"issue":"6","key":"ebr220007r14","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1080\/10410236.2019.1584781","article-title":"Direct-to-consumer advertising of prescription drugs and the patient-prescriber encounter: a systematic review.","volume":"35","author":"DeFrank","year":"2020","journal-title":"Health Commun"},{"issue":"2","key":"ebr220007r15","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1038\/nrc2999","article-title":"Cancer-related direct-to-consumer advertising: a critical review.","volume":"11","author":"Kontos","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"ebr220007r2","unstructured":"US Food and Drug Administration. FDA approves first treatment for thyroid eye disease. January 21, 2020. Accessed October 19, 2021. https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-first-treatment-thyroid-eye-disease"},{"key":"ebr220007r3","unstructured":"Klahr Coey? S, Snyder Bulik? B. Horizon switched up strategy for Tepezza launch, moving quickly to DTC to reach eye disease patients. January 19, 2021. Accessed October 18, 2021. https:\/\/www.fiercepharma.com\/marketing\/horizon-uses-eye-catching-animation-for-ted-ads"},{"key":"ebr220007r4","unstructured":"Listen to Your Eyes Facebook page. Accessed October 19, 2021. https:\/\/www.facebook.com\/ThyroidEyes\/"},{"key":"ebr220007r9","unstructured":"Rogers? S. What is Google Trends data\u2014and what does it mean? July 1, 2016. https:\/\/medium.com\/google-news-lab\/what-is-google-trends-data-and-what-does-it-mean-b48f07342ee8"},{"key":"ebr220007r11","unstructured":"iSpot.tv. Tepezza TV spot, \u201cJeanne.\u201d Accessed October 18, 2021. https:\/\/www.ispot.tv\/ad\/O684\/tepezza-jeanne"}],"container-title":["JAMA Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/articlepdf\/2791596\/jamaophthalmology_strawbridge_2022_br_220007_1654722565.44065.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T15:02:33Z","timestamp":1655391753000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/fullarticle\/2791596"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,1]]},"references-count":15,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaophthalmol.2022.1000","relation":{},"ISSN":["2168-6165"],"issn-type":[{"value":"2168-6165","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6,1]]}}}